4//SEC Filing
Turtle Cameron 4
Accession 0000950170-24-010904
CIK 0001636282other
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 8:31 PM ET
Size
5.5 KB
Accession
0000950170-24-010904
Insider Transaction Report
Form 4
Turtle Cameron
DirectorChief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-02-01+277,750→ 277,750 totalExercise: $25.86Exp: 2034-02-01→ Common Stock (277,750 underlying)
Footnotes (1)
- [F1]This option represents a right to purchase 277,750 shares of the Issuer's common stock, which will vest in equal monthly installments over four years, subject to the Reporting Person's continued employment with the Issuer at each vesting date.
Documents
Issuer
Spyre Therapeutics, Inc.
CIK 0001636282
Entity typeother
Related Parties
1- filerCIK 0001758363
Filing Metadata
- Form type
- 4
- Filed
- Feb 1, 7:00 PM ET
- Accepted
- Feb 2, 8:31 PM ET
- Size
- 5.5 KB